Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03036254 · ClinicalTrials.gov registry record · NA
Hyperbaric Oxygen Therapy for Cognition in Diabetic Elderly at High Dementia Risk
A NA study of Diabetes Mellitus, sponsored by Icahn School of Medicine at Mount Sinai.
- Completed
- Registry status
- NA
- Development phase
- 155
- Enrollment target
- 4
- Study locations
NCT03036254 is a NA study of Diabetes Mellitus that has completed, run by Icahn School of Medicine at Mount Sinai. The registered enrollment target is 155 participants, below the 1,867-participant average among 208 other Diabetes Mellitus trials with a reported enrollment target (92% lower). The trial reports 4 study locations across 3 states.
The verdict
NCT03036254, a NA study of Diabetes Mellitus, has completed, sponsored by Icahn School of Medicine at Mount Sinai.
- COMPLETED
- Registry status
- NA
- Development phase
- 155 participants
- Enrollment target
- 4
- Study locations
Study Summary
An urgent need exists to identify effective interventions to arrest or reverse dementia and cognitive loss at its earliest stages. The proposed pilot randomized clinical trial will investigate the short and long-term effects of hyperbaric oxygen therapy on cognitive functioning, cerebral blood flow, and glucose uptake in diabetic elderly with mild cognitive impairment. and provide the basis for a large-scale multi-center study of hyperbaric oxygen therapy effects on cognition in diabetes. The potential to preserve, or even enhance, cognition in elderly at high risk of cognitive decline and dementia has major implications for the affected individuals and their support systems that bear the social and financial burdens of long-term caregiving.
Conditions Studied
Interventions
- DEVICE Sham intervention
- DEVICE HBOT intervention
Study Locations (4)
Other
- Sheba Medical Center - Ramat Gan
- Assaf HaRofeh Medical Center - Tzrifin
New York
- Icahn School of Medicine at Mount Sinai - New York
Wisconsin
- University of Wisconsin - Madison
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 155 participants |
| Start Date | 2017-08-10 |
| Est. Completion | 2024-04-15 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03036254
The ClinicalTrials.gov registry entry for NCT03036254 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 155 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 1,867-participant average among 208 other Diabetes Mellitus trials with a reported enrollment target (92% lower). The listed sponsor is Icahn School of Medicine at Mount Sinai, which has 708 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Diabetes Mellitus appearing as the primary indexed condition, and to 2 interventions - of which Sham intervention is the first listed.
NCT03036254 reports 4 study locations spanning 3 distinct geographic areas - top geographies include Other, New York, Wisconsin.
Frequently Asked Questions
What is clinical trial NCT03036254 about?
NCT03036254 is a clinical study titled "Hyperbaric Oxygen Therapy for Cognition in Diabetic Elderly at High Dementia Risk". An urgent need exists to identify effective interventions to arrest or reverse dementia and cognitive loss at its earliest stages. The proposed pilot randomized clinical trial will investigate the short and long-term effects of hyperbaric oxygen therapy on cognitive functioning, cerebral blood flow,...
What is the current status of trial NCT03036254?
This trial is currently completed. It is a NA study. The enrollment target is 155 participants. The study started on 2017-08-10. Estimated completion is 2024-04-15.
What conditions does trial NCT03036254 study?
This clinical trial studies the following conditions: Diabetes Mellitus.
What interventions are being tested in trial NCT03036254?
The interventions under investigation include: Sham intervention (DEVICE), HBOT intervention (DEVICE).
Who is sponsoring clinical trial NCT03036254?
This trial is sponsored by Icahn School of Medicine at Mount Sinai, which has 708 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03036254 being conducted?
This trial has 4 study locations across New York, Wisconsin. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Diabetes Mellitus
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Improving Glycemic Control With Telemedicine and Smart Insulin Pens
RECRUITING · NA
-
Comparing Healthcare Visit Recording and Open Notes to Improve Chronic iLlness Care Experience in Older Adults
RECRUITING · NA
-
Therapeutic Plantar Electrical Stimulation Intervention During Hemodialysis to Improve Balance and Mobility
RECRUITING · NA
-
FAMily-centered WEight Loss for Black Adults (FAM WEL B-ing)
RECRUITING · NA
-
Innovative Multi-Variable Biofeedback for Improving Gait Performance in Individuals With Diabetic Peripheral Neuropathy
RECRUITING · NA
-
Cardiovascular Kidney and Metabolic Health Assessment and Patient Empowerment
RECRUITING · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.